Today in focus: Biontech
In recent months, vaccine stocks have been among the most heavily traded companies on the stock market. Over $250 billion is what Moderna and Biontech are currently worth. Biontech’s performance since its IPO in 2019 has been 2,440%. But this week Biontech had to give up some gains on the stock markets. Concerns about certain…